chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Later the same day after I received vax, Around 8-8:30 i had body aches. Noticed that when my arm is to the side of my body, it started going numb- right arm. I also had to get up around 4 times to urinate a lot. I was getting night sweats. When I would get up, I had a slight head ache and dizziness. I still have it right now, the headache and dizziness. Even when I walk, I have to extend my pinky finger out so my arm will not go numb. As we are speaking right now, my pinky finger is going numb. Once I extend it out, it goes away, but when I put it down by my side, it goes numb. My whole body is sore as well.
Patient received PNEUMOVAX 23 and FLUZONE HD on the same arm an inch apart. Patient stopped by store on 10/13/2016 to show arm swollen and red from shoulder area to elbow. Patient was told to take a diphenhydramine to decrease reaction.
MINUTES AFTER SHE ADMINISTERED JANSSEN'S COVID-19 VACCINE TO  PATIENT. HE FAINTED AND FELL OFF HIS CHAIR. SHE SAID HE CAME TO ALMOST IMMEDIATELY AND SHE HELPED HIM BACK IN THE CHAIR, OFFERING HIM WATER AND A BANANA. HE STAYED SEATED WHILE SHE MONITORED HIS BLOOD PRESSURE, CHECKED FOR PALENESS, AND SWEATING FOR 30 MINUTES. THEN HIS GIRLFRIEND/FRIEND DROVE HIM HOME.
This child was given Varivax 01/14/1998. Chicken pox was observed 12/21/2000.
Arm pain at first but then Got up to go to bathroom, suddenly felt nausea and then numbness on left side of body, vision became blurry and I passed out. Hit head when fell. Couldn?t regain consciousness for 10-20 minutes. Couldn?t move, get off floor. Husband had to come carry me back to bed. Felt tingling in arms, legs on both sides. After an hour, had water, iced arm (extreme arm pain), and felt better but stayed in bed.
I got a tetanus shot. Itching, mass swelling, tender to touch, redness, blotchy rash 3inches by 3inches. Dull muscle pain, difficulty lifting arm and tingling.
Pt devel t105, ?nausea, vomiting, diarrhea; spitting up prior to immun; devel 105R per foster mom; Taken to ER; poss lt OM, ? viral synd;
Case number PHEH2014US020726, is an initial spontaneous report received from a nurse on 13 OCT 2014. This report refers to a 47 year old female patient. Her medical history and concomitant medication was not reported. She was vaccinated with FLUVIRIN 2014/2015 (batch number: 1413201A) 0.5 ml intramuscular on 03 OCT 2014 (6 days later than supposed to get). Nurse stated that the person who opened the cooler stated that the gels packs were still mushy, but temperature unknown. No adverse event was reported. No further information was provided.
Pt states hurting since Tuesday, noticed swelling and redness today 3/31/10. Areas are reddened, warm to touch and swollen bilateral deltoids - R deltoid 70cm x 70 CM and R deltoid 40 cm x 50 cm.
Big red rash; Soreness; Itchy; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (Big red rash), PAIN (Soreness) and PRURITUS (Itchy) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH ERYTHEMATOUS (Big red rash), PAIN (Soreness) and PRURITUS (Itchy). At the time of the report, RASH ERYTHEMATOUS (Big red rash), PAIN (Soreness) and PRURITUS (Itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitants were reported.  Treatment information was not provided.
Right leg was number/in pain from the groin to the foot.; Right leg was number/in pain from the groin to the foot.; The top of both feet started to hurt. 23 days after the first shot and the top of both feet still hurt.; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration on 01Apr2021 at 09:30 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic pelvic pain syndrome (CPPS). The patient had known allergies to sulfamethoxazole; trimethoprim (BACTRIM) and ciprofloxacin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included ascorbic acid (VITAMIN C), bromelains (MANUFACTURER UNKNOWN), biotin (MANUFACTURER UNKNOWN) and quercetin (MANUFACTURER UNKNOWN); all from unknown dates for unknown indications and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 01:30, 16 hours after the vaccination, the patient experienced right leg was number/in pain from the groin to the foot and at that same time patient experienced top of both feet started to hurt. On 23Apr2021, 23 days after the first shot, the patient still experienced top of both feet hurt and right leg still had mild discomfort. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events right leg was number/in pain from the groin to the foot and top of both feet started to hurt was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
I received my second booster on May 25th at 03:00 in the afternoon. On May 26th around noon, I started getting nauseas, bloated, and lightheaded. On May 30th, around 04:00PM, I went to urgent care as my blood pressure went up to 183/81. I do  not have blood pressure problems. I was diagnosed with fatigue. On June 15th, I went to the doctor as an annual visit, but I still had all the symptoms. Right before I went to that appointment, after 8 days of being nauseous 24 hours a day, I called my primary doctor. He prescribed Ondansetron HCL 4mg to be taken every 6 hours. Nausea went away. My doctor examined me and said there was nothing he could do for me because of it being vaccine related. He called it vaccine syndrome. He did prescribe Vitamin B12. Saturday, June 25th, I had a very dizzy spell. I had to call an ambulance. I spent the night admitted to the hospital where many tests were done. I was discharged with vertigo likely secondary to COVID-19 Booster. I went home with a prescription Meclizine 12.5mg. On June 29th, I went to see primary doctor. He examined me. He is sending me to therapy for crystal adjustments and referral to an ENT doctor.
Arm soreness; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 67-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 21st January 2020, the patient received the 1st dose of Shingrix. On 21st January 2020, less than a day after receiving Shingrix, the patient experienced pain in arm. In January 2020, the outcome of the pain in arm was resolved with sequelae.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were reported as follows: The patient received Shingrix vaccine on left arm and she experienced arm soreness for a couple of days following the shot. The reporter consented to follow up. This case has been linked with US2020014925, reported by same reporter.
Day 2-arm soreness and fatigue Day 14- red raised rash on left arm (warm to touch, slight discomfort with itching)
NO ADVERSE EVENT; Incorrect storage PEDV AX HIB was administered to (3) patients on 7/6/2021; This spontaneous report was received from a registered nurse refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not provided.  On 06-JUL-2021, the patient was vaccinated with improper storage haemophilus b conjugate vaccine (meningococcal protein conjugate)(LIQUID PEDVAXHIB) lot # T026961, expiration date 02-APR-2023 (dose, frequency and route were not provided), for prophylaxis. No additional adverse event reported.  Temperature (8.6F) Time frame 45 minutes Previous temperature excursion? N Was call because of a "data logger"? Y; Sender's Comments:  US-009507513-2108USA001447: US-009507513-2108USA001448:
3 hours after the pt received the flu and pneumococcal vaccines, the pt had a sudden onset of fever and productive cough. He called me on 10/4/01 and we began Amantadine 50mg and I saw him on 10/5/01 and heard fine, inspiratory crackles, right greater than left, at the base of the lung when present. Chest X-rays showed pulmovascular congestion with cardiomegaly and new bilateral focal infiltrates consistent with pneumonia. Continued on Amantadine and Toquin 400mg po daily was added. He is much improved on 10/15/01 exam.
Pt recvd 1st dose of Engerix-B 13DEC91 & 1 hrs post vax pt exp hive (?), was flushed, felt warm on trunk & limbs & became itchy;
This spontaneous report was received from a physician via a company representative and refers to a 16-year-old patient (gender not reported). No information regarding the patient's medical history, concomitant therapies, drug reactions and allergies was provided. On 30-AUG-2017, the patient was vaccinated with a dose of GARDASIL 9 injection (dose, frequency, route of administration were not provided; lot # N013276, expiration date 21-JAN-2020), in the left arm. Dose number of GARDASIL 9 was unknown by the reporter. On the same day, the patient was vaccinated with MENACTRA (dose, frequency, route of administration, lot # and expiration date were not provided), in the left arm and meningococcal b outer membrane protein vaccine (detergent) reported as Meningitis B shot (dose, frequency, route of administration, lot # and expiration date were not provided), in the right arm. On approximately 13-SEP-2017 (reported as about 2 weeks later), the patient developed tenderness, soreness and a red lump in the left arm around the injection site. In approximately 2017, the patient experienced numbness and tingling in the fingers of their left hand and the red lump on patient's left arm increased a bit in size. On 10-OCT-2017, the patient sought for medical attention and visited the physician who prescribed ibuprofen to be taken every 6 hours and also did some lab work, diagnostic tests complete blood count, C-reactive protein and erythrocyte sedimentation rate. No product quality complaint involved. The outcome of tenderness, soreness, red lump, numbness and tingling in the fingers of the left hand was not reported. Causality assessment was not provided.
Hives on the face No other symptoms including shortness of breath or facial/lip swelling  Hives resolved after 1 dose of Benadryl
Attendee had an Adverse reaction to first Pfizer Covid 19 vaccine. Became dizzy and sweaty approximately 13 minutes after vaccine.  Laid down on cot with legs up. V/S taken every 5 minutes. After 10 minutes, given cold Gatorade. Did not eat earlier in day. (Was high on Marijuana). Left after 30 minutes with friend. Ambulated by self.
More than 35 days between primary series; This spontaneous case was reported by a patient and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (More than 35 days between primary series) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 011L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (More than 35 days between primary series). On 01-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (More than 35 days between primary series) had resolved.            Date of birth of the patient reported was unspecified date.  No concomitant medications were reported.  No treatment medications were reported   This case was linked to MOD-2021-417297, MOD-2021-417942 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 17-Dec-2021: Follow up received contains no new information.
On July 8, 2019 she was admitted to Hospital and was diagnosed with Kawasaki Disease on 07/10/2019. She received IVIG and is currently taking Aspirin.
Second dose of Pfizer-BioNTech vaccine caused some expected lymphadenopathy on the side in which vaccination was given. Had a longstanding appointment for a mammogram that took place approx 36 hours after second dose received. Accordingly, ultrasound revealed lymphadenopathy and necessitate a follow-up U/S.  Further follow-up will be given in eight weeks to ensure resolution, further to current supposition that the swelling is related to a normal reactivity of lymph nodes following vaccination. I understood already that this was a possibility, given the proximity of the second COVID-19 vaccination and the mammogram, but wanted to report outcome, to add to dataset.
I had some reaction to this, a little bit of pain at the injection site; I was tired; Very light headache; Little bit of muscle pain; Chills; Little joint pain; Fever; Little bit of nausea; I was feeling kind of unwell; soaking wet with sweat; This is a spontaneous report from a contactable consumer or other non hcp. A 74-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number: unknown) via an unspecified route of administration on 03Mar2021 as single dose for covid-19 immunisation. Medical history included atrial fibrillation, blood pressure measurement, all from an unknown date and unknown if ongoing. Concomitant medication(s) included carvedilol (CARVEDILOL) taken for blood pressure measurement, start and stop date were not reported; apixaban (ELIQUIS); amiodarone (AMIODARONE); tamsulosin (TAMSULOSIN); nystatin (STATIN [NYSTATIN]) all taken for an unspecified indication, start and stop date were not reported. On 04Mar2021 the patient experienced I had some reaction to this, a little bit of pain at the injection site, I was tired, very light headache, little bit of muscle pain, chills, little joint pain, fever, little bit of nausea, I was feeling kind of unwell, soaking wet with sweat. Clinical course was reported as 03Mar he got Covid vaccine his first shot at the (state name) hospital in (state name). Okay, he had some reaction to this, a little bit of pain at the injection site, he was tired, a very light headed, little bit of muscle pain but it was not lot, some chills, a little joint pain, a fever, no swelling though at the injection site no redness at the injection site, a little bit of nausea but nothing serious and he was feeling kind of unwell, no swollen lymph nodes and no swelling at the face or no fast heart-beat, no rash and no dizziness a little bit of weakness. He feels great now it's been almost 48 hours since he had the shot so he pretty much over it, but it has I let you know, did have little bit reaction. The patient did not receive any treatment for the adverse events. The clinical outcome of the event was recovered on unspecified date in Mar2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
This spontaneous report was received from a nurse and refers to multiple unspecified patients of unknown ages and genders. There was no information about patient's concomitant medications, drug reactions/allergies and pertinent medical history reported. On unknown dates, the patient were vaccinated with an improperly stored dose of ROTATEQ orally, lot numbers reported as M035456, M040268 and M041181, with expiration date of 01-MAY-2018, 14-MAY-2018 and 31-MAY-2018 respectively (dose was not reported) for prophylaxis.   The vaccines were exposed to temperature excursion of 47 Fahrenheit (F) to 77 Fahrenheit (F) during 10 hours and 12 minutes. There were no previous temperature excursions. The call was because of a "data logger". No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same source. Additional information has been requested.; Sender's Comments: US-009507513-1703USA010669:
Sore throat; I have had a terrible cough and it is so bad that my body aches when I cough; I have had a terrible cough and it is so bad that my body aches when I cough; Headache; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 62-Year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Dose number: unknown, Lot number: EN5318, Expiry date: May2021) via an unspecified route of administration, administered in left arm on 30Jan2021 (age at vaccination was unknown) at a single dose for covid-19 immunisation. Medical history included high blood pressure. Concomitant medication included lisinopril (LISINOPRIL). The patient received the vaccine on 30Jan2021(not clarified) and on the 4th (not clarified), she got a sore throat and then on the 5th (not clarified) and since then she has had a terrible cough and it was so bad that her body aches when she coughs. The patient did not go to any Physician Office/ Emergency Room and was going to go as soon as after she had a talk. That's what she wanted to know if she should go or not. The patient has been taking cough medicine and Tylenol for the headache as a treatment. The outcome of all the events was unknown.
Patient was due for their second monovalent dose but received a Bivalent booster instead.
3rd DOSE MODERNA COVID VACCINE GIVEN 8/31/22, #055A22A; 8/15/2022 Pt had a positive COVID test in Health Center; DNR; comfort care only; pt passed away in the SNF.  FNP, NP took care of this pt at Health Center.
This case was reported by a healthcare professional and described the occurrence of antigenemia in an infant female subject who was vaccinated with Engerix B for prophylaxis.  The infant's date of birth was either 30 June 2007 or 01 July 2007.  The subject's mother was hepatitis C positive and hepatitis B negative.  On 2 July 2007 at 15:30, the newborn subject received 1st dose of Engerix B (unknown).  On 3 July 2007, one day after vaccination with Engerix B, the subject experienced antigenemia.  On 03 July 2007, laboratory analysis revealed that the subject was hepatitis B surface antigen positive.  A repeat laboratory analysis was performed on 04 July 2007 to confirm these results and again revealed she was hepatitis B surface antigen positive.  According to the reporter, the event did not prolong the newborn's hospitalization stay after her birth.  At the time of reporting, the infant had been discharged.  At the time of reporting the event was unresolved.  The healthcare professional considered the event was probably related to vaccination with Engerix B.
COVID infection. Specimen collected on 8/16/21. Patient died on 9/4/21.
Rash/ blisters on arm at vaccine point frist start on Oct 1  as a red spot with many small blisters.   Today not as red but with large blisters.
Ran a fever, starting 3rd day post immunization. Increased irritability, covered head to toe in red spots for 2-3 days.
Patient presented in clinic today to see Dr. for a return OB visit. She is 28 weeks and 4 days gestation who was due for Covid booster, Tdap during pregnancy, and Influenza. The doctor okayed patient to retrieve all immunizations during her visit today. MA and Health Center had gotten the vaccinations ready and had them verified by our RN before dispensing them. After giving the three injections I had notice that I gave the Monovalent Moderna Booster age 6-11 Rather than the Omicron Bivalent Moderna for 18 . Patient did not report any issues or concerns and she has been notified with instructions on when to return for the Bivalent.
felt hot; swollen; rush on the injection site; felt sore; redness on the injection site; lump on the injection site/the lump is small.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (lump on the injection site/the lump is small.), FEELING HOT (felt hot), VACCINATION SITE ERYTHEMA (redness on the injection site), VACCINATION SITE SWELLING (swollen) and VACCINATION SITE RASH (rush on the injection site) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014f21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), LOSARTAN, LORAZEPAM and PARACETAMOL (ACETAMINOPHEN) for an unknown indication.    On 21-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Sep-2021, the patient experienced VACCINATION SITE MASS (lump on the injection site/the lump is small.) and VACCINATION SITE ERYTHEMA (redness on the injection site). On 01-Oct-2021, the patient experienced FEELING HOT (felt hot), VACCINATION SITE SWELLING (swollen), VACCINATION SITE RASH (rush on the injection site) and VACCINATION SITE PAIN (felt sore). At the time of the report, VACCINATION SITE MASS (lump on the injection site/the lump is small.), FEELING HOT (felt hot), VACCINATION SITE ERYTHEMA (redness on the injection site), VACCINATION SITE SWELLING (swollen), VACCINATION SITE RASH (rush on the injection site) and VACCINATION SITE PAIN (felt sore) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Oct-2021, Body temperature: 97.4 (High) 97.4 degree F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment was not received.
tachycardia; anxiety; restlessness; confusion; This is a spontaneous report from a contactable consumer or other non hcp. A 38-years-old non-pregnant female patient received bnt162b2 (BNT162B2; solution for injection;Lot number ep7534 expiry date was not reported), dose 1 via an unspecified route of administration at arm left on 20Mar2021 (at the age of 38-years-old) as a single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Prior to the vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. Patient did not had allergies. Patient dose 2 (Lot number EW0153 expiry date was not reported) via an unspecified route of administration at arm left on 20Mar2021 as a single dose for covid-19 immunisation, On 11Apr2021 tachycardia, anxiety, restlessness, confusion. The patient underwent lab tests and procedures which included sars-cov-2 test negative on 25Apr2021. Therapeutic measures were taken as a result of tachycardia, anxiety, restlessness, confusion. Outcome of the events were recovering.   No follow up attempts are possible. No further information is expected
itchy throat with no tightness or difficulty breathing. Tingling tongue per patient report. Benadryl 50mg given by mouth @ 1503pm. Pt recovered and was discharged in no distress.
This case was reported by a consumer via call center representative and described the occurrence of fatigue in a 64-year-old male patient who received SHINGRIX. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a year after receiving SHINGIRX, the patient experienced fatigue. On an unknown date, the outcome of the fatigue was unknown. It was unknown if the reporter considered the fatigue to be related to SHINGRIX. Additional information was reported as follows: The age at vaccination was not reported. No further information was provided by the caller, as caller refused to provide the further information. This case was linked to case US2018GSK042362 and case US2018GSK042391, reported by the same reporter.